Protagonist Therapeutics Inc Earnings

The next earnings date for Protagonist Therapeutics Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Protagonist Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/05/2025	$-0.61

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Protagonist Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/06/2025	---	$-0.55	5.17%
07/31/2025	---	$0	100.00%
05/05/2025	After Market	$-0.19	-272.73%
02/25/2025	After Market	$1.98	692.00%
11/04/2024	After Market	$-0.54	10.00%
08/06/2024	Before Market	$-0.50	16.67%
05/07/2024	After Market	$3.26	173.95%
02/27/2024	After Market	$0.44	1,566.67%
11/02/2023	After Market	$-0.58	15.94%
08/03/2023	After Market	$-0.68	-4.62%
05/04/2023	After Market	$-0.67	8.22%
03/15/2023	After Market	$-0.69	-7.81%
11/08/2022	After Market	$-0.64	26.44%
08/04/2022	After Market	$-0.84	9.68%
05/04/2022	After Market	$-0.43	31.75%
02/28/2022	After Market	$-0.77	1.28%
11/03/2021	After Market	$-0.70	-4.48%
08/04/2021	After Market	$-0.69	-25.45%
05/04/2021	After Market	$-0.54	5.26%
03/10/2021	After Market	$-0.48	0.00%
11/04/2020	After Market	$-0.21	65.57%
08/06/2020	After Market	$-0.61	-3.39%
05/07/2020	After Market	$-0.72	-4.35%
03/10/2020	After Market	$-0.63	3.08%
11/06/2019	After Market	$-0.61	14.08%
08/07/2019	Before Market	$-1.18	-321.43%
05/08/2019	Before Market	$-0.58	1.69%
03/12/2019	After Market	$-0.57	-21.28%
11/06/2018	After Market	$-0.38	-2.70%
08/07/2018	After Market	$-0.41	-17.14%
05/09/2018	After Market	$-0.36	-24.14%
03/07/2018	After Market	$-0.15	57.14%
11/06/2017	After Market	$-0.29	59.15%
08/08/2017	After Market	$-0.89	-3.49%
05/10/2017	After Market	$-0.84	-37.70%
03/07/2017	After Market	$-0.67	-28.85%
11/14/2016	After Market	$-0.87	-50.00%
09/15/2016	After Market	$-19.07	-2,376.62%

More About Protagonist Therapeutics Inc

Website

https://www.protagonist-inc.com

Country

USA

Full Time Employees

130

Protagonist Therapeutics, Inc., a biopharmaceutical company, develops peptide therapeutics for hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing Rusfertide, an injectable mimetic of hepcidin that is in phase 3 clinical trials for the treatment of polycythemia vera; Icotrokinra, an orally delivered investigational drug which is in phase 3 clinical trials indicated to block biological pathways targeted by marketed injectable antibody drugs; and PN-943, an orally delivered, gut-restricted alpha 4 beta 7 specific integrin antagonist completed a phase 2 clinical trials in patients with moderate to severe ulcerative colitis. The company also develops IL-17 oral peptide antagonist PN-88,1 an oral metabolic/obesity peptide program, and an oral hepcidin mimetic/ferroportin blocker that is in pre-clinical stage. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

“Protagonist Therapeutics Inc Earnings” Can Refer to the Protagonist Therapeutics Inc Earnings Date

Some people say “Protagonist Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Protagonist Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Protagonist Therapeutics Inc Stock on the Earnings Date

If you own Protagonist Therapeutics Inc stock (PTGX) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Protagonist Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Protagonist Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Protagonist Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Protagonist Therapeutics Inc earnings or anything else related to the stock market.